Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
					Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





Sodium fluoroacetate																				Related Pages
										May 1994
Immediately Dangerous to Life or Health Concentrations (IDLH)
**CAS number:** 62–74–8
**NIOSH REL:** 0.05 mg/m3 TWA, 0.15 mg/m3 STEL [skin]
**Current OSHA PEL:** 0.05 mg/m3 TWA [skin]
**1989 OSHA PEL:** 0.05 mg/m3 TWA, 0.15 mg/m3 STEL [skin]
**1993-1994 ACGIH TLV:** 0.05 mg/m3 TWA, 0.15 mg/m3 STEL [skin]
**Description of substance:** Fluffy, colorless to white (sometimes dyed black), odorless powder.
**LEL:** . . Noncombustible Solid
**Original (SCP) IDLH:** 5 mg/m3
**Basis for original (SCP) IDLH:** The chosen IDLH is based on the statement by Deichmann and Gerarde [1969] that the probable lethal oral dose for an adult is 50 mg. No data on acute inhalation toxicity are available on which to base the IDLH for this highly toxic compound.
**Short-term exposure guidelines:** None developed
**ACUTE TOXICITY DATA:**
**Lethal dose data:**

**Species**
    **Reference**
    **Route**
    **LD50** **(mg/kg)**
    **LDLo** **(mg/kg)**
    **Adjusted LD**
    **Derived value**Rat RabbitRatG. pigMouse
    Lehman 1951 McIlroy 1982Ward 1946Ward 1946Yakkyoku 1977
    oral oraloraloraloral
    1.7 0.340.10.30.1
    ----- --------------------
    12 mg/m 2.4 mg/m0.7 mg/m2.1 mg/m0.7 mg/m
    1.2 mg/m30.24 mg/m30.07 mg/m30.21 mg/m30.07 mg/m3**Human data:** The probable oral lethal dose has been reported to be 50 mg [Deichmann and Gerarde 1969]. [Note: An oral dose of 50 mg is equivalent to a worker being exposed to about 30 mg/m3 for 30 minutes, assuming a breathing rate of 50 liters per minute and 100% absorption.]
 
 **Revised IDLH:** 2.5 mg/m3**Basis for revised IDLH:** No inhalation toxicity data are available on which to base an IDLH for sodium fluoroacetate. Therefore, the revised IDLH for sodium fluoroacetate is 2.5 mg/m3 based on acute oral toxicity data in humans [Deichmann and Gerarde 1969].**REFERENCES:**
1. Deichmann WB, Gerarde HW [1969]. Sodium fluoroacetate (1080). In: Toxicology of drugs and chemicals. New York, NY: Academic Press, Inc., p. 542.
2. Lehman AJ [1951]. Chemicals in foods: a report to the Association of Food and drug Officials on current developments. Part II. Pesticides. Section I. Introduction. Q Bulletin Assoc Food Drug Off U.S. *15*(4):122-123.
3. McIlroy JC [1982]. The sensitivity of Australian animals to 1080 poison. III. Marsupial and eutherian herbivores. Australian Wildlife Research *9*:487-503.
4. Ward JC [1946]. Rodent control with 1080, ANTU, and other war-developed toxic agents. Am J Public Health Nations Health *36*:1427-1431.
5. Yakkyoku (Pharmacy) [1977]; *28*(3):329-339 (in Japanese).

			
							
								Page last reviewed:  December 4, 2014						Content
							source: 	National Institute for Occupational Safety and Health NIOSH Publications & Products
Immediately Dangerous To Life or Health (IDLH) Values
Table of IDLH Values
Criteria for Determining IDLH Values
Historical Documentation
Original (SCP) Values
Abbreviations for IDLH Documentation
Abbreviations for Journal Titles Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification/Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
					Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
					You will be subject to the destination website's privacy policy when you follow the link.
					CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue